Cantor Lops PT on Intuitive Surgical (ISRG) to $420; Not Yet at Inflection Point, N-T Catalysts Still Stagnant

Go back to Cantor Lops PT on Intuitive Surgical (ISRG) to $420; Not Yet at Inflection Point, N-T Catalysts Still Stagnant

Intuitive Surgical (ISRG) Remains Outperform at Barrington Despite Deceleration

April 23, 2014 3:26 PM EDT

Barrington Research maintained an Outperform rating on Intuitive Surgical (NASDAQ: ISRG) with a price target of $650. Analyst Charley R. Jones noted that guidance reflects deceleration but he is a buyer on weakness.

"ISRG reported weaker-than-expected Q1/14 results and guidance for the remainder... More

Intuitive Surgical (ISRG) Q1 'a Bust' - Northland Capital Markets

April 23, 2014 8:26 AM EDT

Northland Capital Markets analyst Suraj Kalia reiterated an Underperform rating and $275 price target on Intuitive Surgical (NASDAQ: ISRG) calling Q1 'a bust.'

Kalia commented, "Intuitive's Q1-14 call yesterday had some ominous signs of a different story moving forward. Revs @ $465M completely... More

Intuitive Surgical (ISRG) Target, Estimates Slashed at Jefferies Post Q1; 'Buy' Maintained

April 23, 2014 7:01 AM EDT

Jefferies analyst Imron Zafar cut estimates and his price target on Intuitive Surgical (NASDAQ: ISRG) from $595 to $465 following weak Q1 results.

Zafar states, "1Q was weak across the board, and while a procedure guidance... More

Intuitive Surgical, Inc. (ISRG) Posts Q1 EPS of $1.13

April 22, 2014 4:47 PM EDT

Intuitive Surgical, Inc. (NASDAQ: ISRG) reported Q1 EPS of $1.13, $2.14 worse than the analyst estimate of $3.27. Revenue for the quarter came in at $465 million versus the consensus estimate of $507.04 million.

First quarter 2014 instrument and accessory revenue decreased by approximately 2% to $255 million compared with $261 million for the first quarter of 2013. The decrease in revenue was driven by lower instrument and... More

Intuitive Surgical, Inc. (ISRG) Receives FDA 510(k) Clearance of da Vinci Sp Surgical System

April 22, 2014 8:31 AM EDT

Intuitive Surgical, Inc. (Nasdaq: ISRG) announced it has received FDA 510(k) clearance for the da Vinci Sp Surgical System, which is designed to expand the Company's single-incision product offering. This initial clearance is specific to urologic surgical procedures that are appropriate for a... More